middle.news
PYC Therapeutics Advances RNA Pipeline with $600m Capital Boost and Clinical Milestones
9:36am on Tuesday 28th of April, 2026 AEST
•
Biotechnology
Read Story
PYC Therapeutics Advances RNA Pipeline with $600m Capital Boost and Clinical Milestones
9:36am on Tuesday 28th of April, 2026 AEST
Key Points
Raised $600 million from global life sciences investors
Advanced highest dose cohort in PKD Single Ascending Dose study
FDA alignment on RP11 registrational trial design
Safety and efficacy data presented for ADOA program
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PYC Therapeutics (ASX:PYC)
OPEN ARTICLE